Decibel Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Decibel Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2022.
  • Decibel Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$18.1M, a 6.45% decline year-over-year.
  • Decibel Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$63.4M, a 5.02% decline year-over-year.
  • Decibel Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63M, a 21.6% decline from 2021.
  • Decibel Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$51.8M, a 31.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$63M -$11.2M -21.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 -$51.8M -$12.5M -31.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$39.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.